389 related articles for article (PubMed ID: 35658795)
1. Investigation of systemic immune-inflammation index and systemic inflammation response index as an indicator of the anti-inflammatuary effect of isotretinoin in patients with acne vulgaris.
Cosansu NC; Yuksekal G; Turan U; Umitfer F; Yaldiz M; Sevimli Dikicier B
Cutan Ocul Toxicol; 2022 Jun; 41(2):174-178. PubMed ID: 35658795
[TBL] [Abstract][Full Text] [Related]
2. Effect of isotretinoin treatment on inflammatory and hematological parameters in patients with acne vulgaris.
Esen M
Cutan Ocul Toxicol; 2024 Mar; 43(1):27-32. PubMed ID: 37837334
[TBL] [Abstract][Full Text] [Related]
3. A Novel Inflammatory Marker in the Follow-up of Moderate-to-Severe Acne Vulgaris Administered Isotretinoin: Systemic Immune-Inflammation Index (SII).
Turan Ç; Metin N
Curr Health Sci J; 2022; 48(1):63-67. PubMed ID: 35911945
[TBL] [Abstract][Full Text] [Related]
4. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment?
Kutlu Ö
Cutan Ocul Toxicol; 2020 Mar; 39(1):67-70. PubMed ID: 31809606
[No Abstract] [Full Text] [Related]
5. Can monocyte/HDL show inflammatory activity of isotretinoin treatment in acne patients?
Önder S; Ozturk M
Cutan Ocul Toxicol; 2020 Jun; 39(2):111-114. PubMed ID: 32100587
[No Abstract] [Full Text] [Related]
6. Evaluation of systemic immune and inflammatory biomarkers in hidradenitis suppurativa.
Utlu Z
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9267-9272. PubMed ID: 37843340
[TBL] [Abstract][Full Text] [Related]
7. A novel predictive method for risk stratification in acne patients receiving isotretinoin: an analysis of laboratory abnormalities and changes in inflammatory parameters.
Murshidi R; Bani Hamad S; Al Refaei A; Shewaikani N; Shaf'ei M; Alshoubaki SN; Haddad TA; Khasawneh T; Fkheideh T; Abdallat M
J Dermatolog Treat; 2024 Dec; 35(1):2301435. PubMed ID: 38186323
[TBL] [Abstract][Full Text] [Related]
8. Is mean platelet volume an inflammatory marker in acne patients treated with isotretinoin?
Tamer F; Yuksel ME; Avcı E
Acta Dermatovenerol Alp Pannonica Adriat; 2019 Jun; 28(2):65-69. PubMed ID: 31233169
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
10. Increases in uric acid and monocyte-high-density lipoprotein ratio as possible atherosclerotic indicators in acne patients using isotretinoin.
Metin N; Turan Ç
J Cosmet Dermatol; 2021 Sep; 20(9):2945-2949. PubMed ID: 33387386
[TBL] [Abstract][Full Text] [Related]
11. Systemic isotretinoin has an impact on hemoglobin, ferritin, urea, ceruloplasmin, albumin, uric acid levels, and neutrophil to lymphocyte ratio in acne patients.
Hareedy MS; Tawfik KM
J Cosmet Dermatol; 2022 Nov; 21(11):6191-6198. PubMed ID: 35770307
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients.
Zhang Y; Qian H; Kuang YH; Wang Y; Chen WQ; Zhu W
Arch Dermatol Res; 2024 May; 316(6):229. PubMed ID: 38787405
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of peripheral lymphocyte subsets in acne vulgaris patients before and after systemic isotretinoin treatment.
Gunaydin SD; Tezcan I
Indian J Pharmacol; 2022; 54(5):338-344. PubMed ID: 36537402
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma.
Guo J; Lv W; Wang Z; Shang Y; Yang F; Zhang X; Xiao K; Zhang S; Pan X; Han Y; Zong L; Hu W
Cancer Control; 2023; 30():10732748221148913. PubMed ID: 36599103
[TBL] [Abstract][Full Text] [Related]
15. Investigation of monocyte HDL ratio as an indicator of inflammation and complete blood count parameters in patients with acne vulgaris.
Turkmen D; Altunisik N; Sener S
Int J Clin Pract; 2020 Dec; 74(12):e13639. PubMed ID: 32741037
[TBL] [Abstract][Full Text] [Related]
16. The role of first trimester serum inflammatory indexes (NLR, PLR, MLR, SII, SIRI, and PIV) and the β-hCG to PAPP-A ratio in predicting preeclampsia.
Seyhanli Z; Bayraktar B; Baysoz OB; Karabay G; Sucu ST; Ulusoy CO; Aktemur G; Bucak M; Cakir BT; Kurt D; Ergani SY; Iskender CT
J Reprod Immunol; 2024 Mar; 162():104190. PubMed ID: 38219631
[TBL] [Abstract][Full Text] [Related]
17. Laboratory Abnormalities in Acne Patients Treated With Oral Isotretinoin: A Retrospective Epidemiological Study.
Alajaji A; Alrawaf FA; Alosayli SI; Alqifari HN; Alhabdan BM; Alnasser MA
Cureus; 2021 Oct; 13(10):e19031. PubMed ID: 34853752
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte-related ratios, systemic immune-inflammatory and systemic inflammatory response index in alcohol use disorder.
Kok Kendirlioglu B; Arat Celik HE; Buyuksandalyaci Tunc AE; Ozmen M; Corekli Kaymakcı E; Demir S; Kuçukgoncu S
J Immunoassay Immunochem; 2024 Jan; 45(1):38-49. PubMed ID: 37953614
[TBL] [Abstract][Full Text] [Related]
19. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris.
Öktem A; Hayran Y; Arı E; Yalçın B
J Dermatolog Treat; 2019 Dec; 30(8):813-817. PubMed ID: 30836808
[No Abstract] [Full Text] [Related]
20. Evaluation of hematological parameters in patients using systemic isotretinoin with diagnosis of acne vulgaris.
Demirci Saadet E; Sahin U
J Cosmet Dermatol; 2023 Mar; 22(3):1077-1082. PubMed ID: 36437707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
